Clinical-stage Redx Pharma, Jounce Therapeutics sign $425m merger deal

Redx Pharma, a UK-based clinical-stage biotechnology company, and Jounce Therapeutics, a Nasdaq-listed clinical-stage immunotherapy company, have agreed to merge in an all-stock deal that values ... Read More